| oxycodone vs King | 17–19 | 47.22% |
| oxycodone vs Lili | 17–16 | 51.52% |
| oxycodone vs Hwoarang | 14–16 | 46.67% |
| oxycodone vs Jin | 9–21 | 30.00% |
| oxycodone vs Law | 13–6 | 68.42% |
| oxycodone vs Yoshimitsu | 9–10 | 47.37% |
| oxycodone vs Nina | 10–8 | 55.56% |
| oxycodone vs Reina | 10–6 | 62.50% |
| oxycodone vs Kazuya | 8–7 | 53.33% |
| oxycodone vs Devil Jin | 6–7 | 46.15% |
| oxycodone vs Fahkumram | 12–1 | 92.31% |
| oxycodone vs Jun | 8–4 | 66.67% |
| oxycodone vs Victor | 7–5 | 58.33% |
| oxycodone vs Eddy | 7–5 | 58.33% |
| oxycodone vs Steve | 7–4 | 63.64% |
| oxycodone vs Dragunov | 4–7 | 36.36% |
| oxycodone vs Kuma | 7–4 | 63.64% |
| oxycodone vs Leroy | 8–2 | 80.00% |
| oxycodone vs Lars | 3–6 | 33.33% |
| oxycodone vs Lidia | 6–3 | 66.67% |
| oxycodone vs Paul | 3–5 | 37.50% |
| oxycodone vs Azucena | 4–4 | 50.00% |
| oxycodone vs Asuka | 1–6 | 14.29% |
| oxycodone vs Leo | 4–2 | 66.67% |
| oxycodone vs Lee | 3–3 | 50.00% |
| oxycodone vs Bryan | 3–2 | 60.00% |
| oxycodone vs Clive | 3–2 | 60.00% |
| oxycodone vs Xiaoyu | 3–1 | 75.00% |
| oxycodone vs Alisa | 1–2 | 33.33% |
| oxycodone vs Shaheen | 3–0 | 100.00% |
| oxycodone vs Anna | 2–1 | 66.67% |
| oxycodone vs Raven | 2–0 | 100.00% |
| oxycodone vs Heihachi | 0–2 | 0.00% |
| oxycodone vs Jack-8 | 1–0 | 100.00% |
| oxycodone vs Panda | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.